- Home
- GTY vs KNSA Comparison
GTY vs KNSA Comparison
Compare GTY & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTY
- KNSA
- Stock Information
- Founded
- GTY 1955
- KNSA 2015
- Country
- GTY United States
- KNSA United Kingdom
- Employees
- GTY N/A
- KNSA N/A
- Industry
- GTY Real Estate
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- GTY Finance
- KNSA Health Care
- Exchange
- GTY Nasdaq
- KNSA Nasdaq
- Market Cap
- GTY 1.6B
- KNSA 1.6B
- IPO Year
- GTY N/A
- KNSA 2018
- Fundamental
- Price
- GTY $31.25
- KNSA $22.26
- Analyst Decision
- GTY Buy
- KNSA Strong Buy
- Analyst Count
- GTY 4
- KNSA 6
- Target Price
- GTY $33.25
- KNSA $37.17
- AVG Volume (30 Days)
- GTY 345.8K
- KNSA 684.1K
- Earning Date
- GTY 04-23-2025
- KNSA 04-22-2025
- Dividend Yield
- GTY 6.14%
- KNSA N/A
- EPS Growth
- GTY 8.70
- KNSA N/A
- EPS
- GTY 1.25
- KNSA N/A
- Revenue
- GTY $203,391,000.00
- KNSA $423,239,000.00
- Revenue This Year
- GTY $7.27
- KNSA $37.21
- Revenue Next Year
- GTY $5.50
- KNSA $1.38
- P/E Ratio
- GTY $24.51
- KNSA N/A
- Revenue Growth
- GTY 9.44
- KNSA 56.60
- 52 Week Low
- GTY $25.70
- KNSA $16.56
- 52 Week High
- GTY $33.85
- KNSA $28.15
- Technical
- Relative Strength Index (RSI)
- GTY 57.16
- KNSA 51.74
- Support Level
- GTY $30.31
- KNSA $22.62
- Resistance Level
- GTY $30.86
- KNSA $23.42
- Average True Range (ATR)
- GTY 0.54
- KNSA 0.72
- MACD
- GTY 0.02
- KNSA -0.09
- Stochastic Oscillator
- GTY 85.61
- KNSA 24.13
About GTY Getty Realty Corporation
Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.